Cartilage
-
Biologics
Allosource’s Cartilage Allograft Expertise to be Featured at the International Cartilage Regeneration & Joint Preservation Society Annual Meeting
CENTENNIAL, Colo., April 5, 2022 /PRNewswire/ — AlloSource®, one of the largest allograft providers creating innovative cellular and tissue allografts to help surgeons…
Read More » -
Extremities
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
According to a Two-Year Randomized and Controlled Multinational IDE Study KFAR SABA, Israel, Aug. 3, 2021 /PRNewswire/ — CartiHeal Ltd, developer of Agili-C™,…
Read More » -
Biologics
Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research
CENTENNIAL, Colo., Dec. 8, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products…
Read More » -
Sports Medicine
AlloSource Announces First Patients Complete 12-Month Milestone In ProChondrix CR Clinical Study For Cartilage Defects In The Knee
CENTENNIAL, Colo., Nov. 17, 2020 /PRNewswire/ –AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
New Approach to Treating Osteoarthritis Advances
NEW YORK, Aug. 10, 2020 /PRNewswire/ — Injections of a natural “energy” molecule prompted regrowth of almost half of the cartilage lost…
Read More » -
Biologics
Novel Tissue Preservation Method Improves Outcomes in Cartilage Transplant Procedures in the Knee
COLUMBIA, Mo. (July 8, 2020) ― A University of Missouri study on clinical outcomes after biologic knee restoration surgery found…
Read More » -
Biologics
Nanostructured rubber-like material with optimal properties could replace human tissue
March 16, 2020 / Chalmers University of Technology Researchers from Chalmers University of Technology, Sweden, have created a new, rubber-like…
Read More » -
Extremities
Paragon 28® Launches Unique Option for Revising a Failed Synthetic Cartilage Implant (SCI)
ENGLEWOOD, Colo., Dec. 13, 2019 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery.…
Read More » -
Biologics
Research Shows ProChondrix® CR Maintains Consistent, High Cell Viability For Two Years
CENTENNIAL, Colo., Oct. 7, 2019 /PRNewswire/ — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
Read More » -
Biologics
Educate Your Patients…or They Will Take Medical Advice From Their Hairdresser
By Elizabeth Hofheinz, M.P.H., M.Ed., August 30, 2019 “When it comes to stem cells and PRP, we wage a battle…
Read More » -
Biologics
AlloSource Celebrates 25 Years Of Doing More With Life
CENTENNIAL, Colo., Aug. 9, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, will…
Read More » -
Hospitals
SpinalCyte, LLC Announces New U.S. Patent
August 28, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human…
Read More »